CONOBEA SCOPARIOIDES LEAF OIL.

Conobea Scoparioides Leaf Oil presents a high risk for 'dusting' due to its potent biological activities, particularly concerning its observed toxicity. Preliminary studies report high toxicity in the Artemia salina lethality test with an LC50 of 4.49–7.7 µg/mL (equivalent to approximately 0.00045%–0.00077%). While cosmetic formulations often utilize this oil for fragrance at concentrations ranging from 0.2% to 3%, these levels are significantly higher than those demonstrating acute toxicity in initial screens. Marketers might emphasize the antioxidant or 'cellular activity' findings without adequately addressing the substantial toxicity concerns and the lack of direct human dermal safety data for these concentrations, especially when extrapolating from cancer research to healthy skin applications.

Conobea Scoparioides Leaf Oil lacks review by key cosmetic safety bodies such as CIR, SCCS, or FDA. Comprehensive dermal safety data, including human patch tests and long-term exposure studies, are unavailable. Preliminary toxicity tests, specifically the Artemia salina lethality bioassay, indicated high toxicity with an LC50 of 4.49–7.7 μg/mL. Furthermore, in silico analysis of its major constituents revealed moderate toxicity for thymol and methylthymol, and high toxicity for p-cymene. These data collectively raise significant safety concerns for its use in cosmetic products, especially at typical fragrance concentrations.